摘要
目的：探讨氯沙坦治疗尿毒症血液透析患者高血压的临床观察。方法选取2013年12月～2014年12月我院接诊的41例尿毒症血液透析高血压患者，随机分为21例实验组和20例对照组，实验组给予氯沙坦药物，对照组给予哌唑嗪药物，观察两组患者的治疗效果。结果实验组患者的治疗有效率、血压变化情况及尿毒症变化情况优于对照组，P＜0.05，差异具有统计学意义。结论氯沙坦治疗尿毒症血液透析病人高血压的临床效果显著，可以有效降低收缩压和舒张压，改善尿毒症情况。
Objective TLosartan medication in treatment of uremia hemodialysis patients with hypertension is to be studied clinically. Methods Choose 41 uremia hemodialysis patients with hypertension who are received and treated in hospital from December 2013 to December 2014＆amp;nbsp;and separate them into two groups at random, 21 patients in study group are given losartan medication treatment, while 20 patients in control group are given prazosin medication treatment, and then observe and compare treatment effects between two groups.Results Patients’ treatment efifcacy, blood pressure improvement and uremia changes in study group are much more favorable than counterparts in control group,there is a treatment differential between two groups, and such a differential has statistic value （P〈0.05）.Conclusion Losartan medication is of clinical efifcacy in treatment of uremia hemodialysis patients with hypertension; it is conducive to reducing systolic and diastolic blood pressure and improving patients’ uremia symptom.
出处
《中国继续医学教育》
2015年第10期237-238,共2页
China Continuing Medical Education
